Biotech · Private company
Vergent Bioscience, Inc.
Track this companyFree. Adds Vergent Bioscience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AbenacianinePhase 3 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Near Infrared (NIR) ImagingPhase 3 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- VGT-309Phase 2 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the LungPHASE3 · RECRUITING · started Mar 31, 2026ClinicalTrials.gov NCT07499674 · fetched Nov 12, 2026
- Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.PHASE2 · COMPLETED · started Oct 5, 2023ClinicalTrials.gov NCT06145048 · fetched Nov 12, 2026
- Phase 2 Study of VGT-309 in Lung CancerPHASE2 · COMPLETED · started May 24, 2022ClinicalTrials.gov NCT05400226 · fetched Nov 12, 2026